Closing Knowledge Gaps in Osteoarthritis and Osteoarthritis Pain – Request for Proposals/Applications

Well-being, Health and Biomedical Discovery


Academic Unit: Inquire with your unit

Memorial Deadline: Inquire to RGCS

External Deadline: Friday 20th, August 2021


Pfizer and Lilly are collaborating to provide grant support for continuing professional education in the areas of Osteoarthritis/ Osteoarthritis Pain. We are committed to supporting innovative, independent medical education for healthcare professionals. Grants via this collaboration will be funded by Pfizer but reviewed and approved by both companies.

Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Through this RFP we encourage organizations to submit grant requests that, if funded, will support education in a specific disease state, therapeutic area, or broader area of educational need. Educational activities should not be focused on products specific to Pfizer and/or Lilly.

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

Applications are open now and accepted up to and including August 20, 2021

Application               Decision                          Anticipated Project
Submitted by            Notification Date            Start Date                

March 19, 2021         April 2021                       After May 15, 2021

June 18, 2021          July 2021                        After August 15, 2021

August 20, 2021      September 2021            After October 15, 2021

Additional information can be found here.

Funding Sources

Pfizer Inc

This opportunity was posted by: RGCS

Last modified: March 5, 2021